文献速递其他结缔组织病

空间多组学解析系统性硬化症中成纤维细胞与巨噬细胞动态

Spatial multiomics decipher fibroblast-macrophage dynamics in systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2025-05-22

研究对10例弥漫性皮肤型系统性硬化症患者和4例健康对照的皮肤活检进行空间转录组学分析,共分析14份皮肤活检,发现系统性硬化症中成纤维细胞和巨噬细胞富集的纤维化生态位显著扩展并与临床严重程度相关,ACKR3在肌成纤维细胞前体中选择性表达,抑制CXCR4可减轻实验性纤维化小鼠模型的皮肤和肺纤维化。

要点

  • 系统性硬化症皮肤中成纤维细胞和巨噬细胞富集的纤维化生态位显著扩展,与临床严重程度相关。
  • 基于特征基因分层可识别进行性疾病和治疗无反应表型的系统性硬化症患者。
  • ACKR3在肌成纤维细胞前体中选择性表达,分化至成熟肌成纤维细胞时减少。

核心结论

  • 空间分辨图谱揭示成纤维细胞与巨噬细胞动态互作是纤维化生态位扩展的标志。
  • 这些发现为疾病机制提供时空见解,并为先进机制和治疗研究铺平道路,弥合组学发现与精准医学之间的差距。

研究设计与样本

  • 对10例弥漫性皮肤型系统性硬化症患者和4例健康对照的皮肤活检,使用10× Visium平台进行空间转录组学分析。
  • 使用更高分辨率的Stereo-seq转录组学、空间蛋白质组学和来自系统性硬化症患者、系统性硬化症小鼠模型及伤口愈合驯鹿模型的单细胞RNA测序数据确认发现。
  • 进行体内和体外研究验证关键调控通路。

主要发现

  • 共分析14份皮肤活检,显示系统性硬化症中成纤维细胞和巨噬细胞富集的纤维化生态位显著扩展,与临床严重程度相关。
  • 揭示成纤维细胞和巨噬细胞的疾病特异性细胞状态,并评估其空间依赖性和细胞间通讯。
  • 基于特征基因分层可识别进行性疾病和治疗无反应表型的系统性硬化症患者。
  • ACKR3(一种CXCL12诱饵受体)在肌成纤维细胞前体中选择性表达,向成熟肌成纤维细胞分化过程中减少,可能用于调节CXCL12/CXCR4介导的促炎巨噬细胞募集。
  • 抑制CXCR4减轻实验性纤维化小鼠模型的皮肤和肺纤维化。

关键数值与推荐

  • 共分析14份皮肤活检,包括10例弥漫性皮肤型系统性硬化症患者和4例健康对照。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Stromal-immune crosstalk shapes the pathogenic microenvironment of systemic sclerosis (SSc), but the spatial regulatory networks underlying fibrogenesis remain poorly defined. We aimed to explore tissue organisation and cell coordination in SSc skin, providing spatiotemporal insights into disease mechanisms and bridging the gap between omics discovery and precision medicine. METHODS: We performed spatial transcriptomics on skin biopsies from 10 patients with diffuse cutaneous SSc and 4 healthy controls using the 10× Visium platform. These findings were confirmed using higher-resolution Stereo-seq transcriptomics, spatial proteomics, and single-cell RNA sequencing data from patients with SSc, SSc mouse models, and wound-healing reindeer models. In vivo and in vitro studies were conducted to validate the key regulatory pathways. RESULTS: Fourteen skin biopsies were analysed, revealing significant expansion of fibrotic niches enriched with fibroblasts and macrophages in SSc, correlating with clinical severity. We revealed disease-specific cell states of fibroblasts and macrophages and evaluated their spatial dependency and cell-cell communication. Stratification based on signature genes enabled the identification of patients with SSc with progressive disease and treatment-nonresponsive phenotype. ACKR3 (a CXCL12 decoy receptor) was selectively expressed in myofibroblast progenitors, which diminished during differentiation towards mature myofibroblast, potentially serving to regulate CXCL12/CXCR4-mediated proinflammatory macrophage recruitment. Inhibition of CXCR4 attenuated skin and lung fibrosis in experimental fibrosis mouse models. CONCLUSIONS: Our spatially resolved atlas uncovered dynamic fibroblast-macrophage interplay as a hallmark of fibrotic niche expansion. These findings offer spatiotemporal insights into disease mechanisms and pave the way for advanced mechanistic and therapeutic studies, bridging the gap between omics discovery and precision medicine.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Li Z, Rius Rigau A, Xie W, et al. Spatial multiomics decipher fibroblast-macrophage dynamics in systemic sclerosis. Ann Rheum Dis. 2025. PMID: 40410053. doi:10.1016/j.ard.2025.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。